PubMed:11301317 / 1211-1409
Annnotations
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T10","span":{"begin":0,"end":198},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":198},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In contrast, a different PITX2 homeodomain mutant, T68P, which is also defective in DNA binding, transactivation, and Pit-1 synergism activities, did not suppress the wild type synergism with Pit-1."}
UBERON-AE
{"project":"UBERON-AE","denotations":[{"id":"PD-UBERON-AE-B_T4","span":{"begin":118,"end":121},"obj":"http://purl.obolibrary.org/obo/UBERON_0016566"},{"id":"PD-UBERON-AE-B_T5","span":{"begin":192,"end":195},"obj":"http://purl.obolibrary.org/obo/UBERON_0016566"}],"text":"In contrast, a different PITX2 homeodomain mutant, T68P, which is also defective in DNA binding, transactivation, and Pit-1 synergism activities, did not suppress the wild type synergism with Pit-1."}
performance-test
{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T4","span":{"begin":118,"end":121},"obj":"http://purl.obolibrary.org/obo/UBERON_0016566"},{"id":"PD-UBERON-AE-B_T5","span":{"begin":192,"end":195},"obj":"http://purl.obolibrary.org/obo/UBERON_0016566"}],"text":"In contrast, a different PITX2 homeodomain mutant, T68P, which is also defective in DNA binding, transactivation, and Pit-1 synergism activities, did not suppress the wild type synergism with Pit-1."}